Science & Enterprise subscription

Please share Science & Enterprise

RSS
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Start-Up Developing Regenerative Liver Disease Treatments

Damaged liver cells

A new enterprise founded by scientists, is underway developing treatments for advanced liver disorders that combine new drugs with cell and gene therapies to restore or replace liver functions. . . . → Read More: Start-Up Developing Regenerative Liver Disease Treatments

Biotechs Partner on Antibody, T-Cell Cancer Therapies in $100M Deal

T-cells illustration

Two biotechnology companies with complementary technologies plan to create treatments for cancer that harness and modify cells from the immune system delivered with benign viruses. . . . → Read More: Biotechs Partner on Antibody, T-Cell Cancer Therapies in $100M Deal

Infographic – Harvard or Stanford? Venture Capitalists Revealed.

Venture capitalist demographics

Our reporting on venture capital, much like other business media, tells about the companies investing in early-stage enterprises, but what about the people in the industry? . . . → Read More: Infographic – Harvard or Stanford? Venture Capitalists Revealed.

Engineered Bacteria Studied for Rare Inherited Skin Disorder

f Staphylococcus epidermidis

A biotechnology company and research lab are evaluating a modified skin bacteria as a treatment for Netherton syndrome, a rare inherited skin disease affecting mainly infants and young children. . . . → Read More: Engineered Bacteria Studied for Rare Inherited Skin Disorder

NIH Small Business Grant Funds Severe Hepatitis Treatment

RNA strand illustration

A biotechnology company is developing treatments for a severe form of hepatitis, which up to now has only limited therapy options, with a synthetic form of RNA designed to shut down the infecting virus. . . . → Read More: NIH Small Business Grant Funds Severe Hepatitis Treatment

Challenges Seek Solutions for Chronic Diseases, Oral Drugs in Animals

Puppy at veterinarian

Two new crowdsourcing competitions announced this week are seeking ideas on broadening the scope of drugs being developed for companion animals, and making drugs easier to give to pets and farm animals. . . . → Read More: Challenges Seek Solutions for Chronic Diseases, Oral Drugs in Animals

Univ. Spin-Off Developing Myelin Disease Treatments Unveiled

Neurons

A spin-off enterprise from Case Western Reserve University is developing therapies designed to restore the myelin sheath around nerve cells destroyed in multiple sclerosis and other neurological disorders. . . . → Read More: Univ. Spin-Off Developing Myelin Disease Treatments Unveiled

GSK, 23andMe Ink Precision Meds Discovery Deal

Saliva sample kit

Consumer genetics company 23andMe signed a 4-year agreement to help drug maker GlaxoSmithKline find more precise drug targets and recruit clinical trial participants likely to respond to treatments. . . . → Read More: GSK, 23andMe Ink Precision Meds Discovery Deal

Gates, Lauder Backing Early Alzheimer’s Biomarker Tests

Brain circuits

A group of well-known philanthropists is backing a new research program to find simple tests that reveal early indicators of Alzheimer’s disease in a person’s molecular make-up. . . . → Read More: Gates, Lauder Backing Early Alzheimer’s Biomarker Tests

A.I. Drug Discovery Company Gains $32M in Early Funds

Brain hemispheres graphic

A company using genomic databases and artificial intelligence to discover new therapies for neurodegenerative diseases is raising $32 million in its first venture funding round. . . . → Read More: A.I. Drug Discovery Company Gains $32M in Early Funds